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The purpose of this review is to determine the effects of psychosocial stress on 
antibody response to vaccination in humans, consider possible mechanisms, and identify 
agenda for future research.  Studies of the association between stress and vaccination 
response in humans were reviewed.  There is evidence of a negative association between 
stress and antibody response to vaccination, which is most apparent with thymus-
dependent vaccines and when measured at extended times after vaccination.  Preliminary 
findings implicate the hypothalamic-pituitary-adrenal axis and sympathetic nervous 
system as potential mechanisms, although a role for unhealthy behaviours cannot be 
discounted at this stage. Results to date are sufficiently indicative to direct future research 
to untangling their theoretical ramifications, as well as realising their clinical 
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1.  Introduction  
 
A link between psychological stress and increased susceptibility to infectious disease has 
been reported anecdotally for many years.  In 1884, the editor of the British Medical 
Journal noted that at funerals “the depression of spirits under which the chief mourners 
labour at these melancholy occasions peculiarly predisposes them to some of the worst 
effects of the chill” [1].  Since then, morbidity has been shown to be significantly 
increased during chronic stress in both observational [2-5] and live virus challenge [6-9] 
studies.  These provide compelling evidence that psychological stress is associated with 
an impairment of the immune system’s ability to respond to infection.   
 
This interaction between psychological stress and immunity has been a prolific area of 
research over the past two decades (for comprehensive review of this literature, see [10]).  
People experiencing periods of chronic stress have been shown reductions in the number 
of helper T-lymphocytes [11-13], B-lymphocytes [14], and salivary concentrations of 
secretory immunoglobulin A (sIgA) [15-18], compared to controls.  The clinical 
implications of reductions in these cell counts in healthy people, and within normal 
ranges, are unclear [19].  Changes in cell number may just reflect changes in the 
dynamics of lymphocyte migration and recirculation, and other factors, such as shifts in 
plasma volume, rather than absolute changes in total cell numbers.  In addition, absolute 
changes in cell number will not necessarily result in a significant change in the capacity 
of the lymphoid system to make an effective response to antigenic challenge [19].  It is 
difficult, therefore, to account for stress-related increases in disease susceptibility in 
terms of changes in enumerative immune measures.   
 
In vitro measures of immune function, such as lymphocyte proliferation to mitogen, 
have also been shown to be susceptible to stress-induced alterations [12, 20-26].  These 
functional assays give a better indication of immune status than the enumerative methods, 
as proliferation in response to antigen is a key component of the immune response.  
However, studies of polyclonal stimulations do not allow conclusions to be drawn 
regarding the relative susceptibility to stress of particular lymphocyte subsets.  It is also 
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difficult to generalise these in vitro findings to in vivo processes [19].  The isolated 
testing of any particular aspect of the network of immune cells provides scant 
information about the status of the highly integrated, complex immune system and, as 
such, has limited application to overall understanding of the relationship between stress 
and susceptibility to disease.   
 
Measurement of antibody response to specific antigen challenge in vivo provides a 
model for studying integrated immune responses.  Stress may alter both quantity and 
quality of antigen-specific antibody present at different times after immunisation by 
modulating a variety of processes within the immune response.  Stress might affect the 
primary immune response in a number of broad areas, including 1) T-lymphocyte clonal 
expansion and maturation to T-helper-2 (Th2) primed effector lymphocytes and memory 
lymphocytes, 2) initial B-lymphocyte clonal expansion and production of IgM from short 
lived plasma cells in the secondary lymphoid tissues, and 3) germinal centre production 
of memory lymphocytes and plasma cells secreting high affinity IgG and IgA antibody.  
Stress may also impact on the long term maintenance of serum IgG levels against the 
priming antigen; this relies on the maintenance of a memory B-lymphocyte pool and 
further production of antigen specific plasma cells from germinal centre follicles where 
there is a long term deposit of antigen complexed with antibody bound to the surface of 
follicular dendritic cells.  Finally, stress may affect the antibody response to a second 
encounter with antigen, not only by affecting B-lymphocytes, but also via alterations in 
the size of the antigen specific Th2 lymphocyte pool. The size and effectiveness of this 
pool is of particular importance to the speed and size of secondary antibody responses.  
As well as providing a model of the in vivo immune response, the existence of different 
types of vaccine (i.e. thymus-dependent, thymus-independent, and conjugate) allows 
examination of which aspects of the immune system may be influenced by stress.  If, for 
example, the effects of stress are restricted to antibody responses to thymus-dependent 
and conjugate vaccines, this could suggest that T-lymphocytes are more susceptible than 
B-lymphocytes.  Response to vaccination, therefore, provides an ideal way to assess the 
integrated immune response to antigen with clinically relevant outcome measures.  
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2.  Psychological stress: concepts and measurement 
 
Psychological stress can be conceptualised as the extent of exposure to presumed 
stressful environmental and social life events or as the degree to which an individual 
perceives such events as stressful.  Most contemporary definitions of psychological stress 
emphasise the importance of individual perception and appraisal in determining impact.  
For example, Lazarus and Folkman [27] defined stress as “a particular relationship 
between the person and the environment that is appraised by the person as taxing or 
exceeding his or her resources and endangering his or her well-being”.  The duration of 
the stress experience is also important.  Broadly speaking, stressors can be characterised 
as chronic or acute.  Chronic stressors are enduring, major life stressors such as 
bereavement or divorce.  In contrast, acute stressors are the daily hassles that are 
experienced by everyone, ranging in severity from finding a parking space to arguments 
with partner.  Other psychological concepts commonly reported in this literature include 
well-being, negative affect (the experience of aversive mood states such as anger and 
guilt), and anxiety. These can be categorised as state or trait; state conditions are 
transient, existing at a given moment in time or in response to a particular situation, 
whereas trait conditions are relatively stable individual characteristics [28].   
 
Psychological stress levels are commonly measured using standard, validated 
questionnaires.  For example, life event exposure can be assessed by asking participants 
to indicate which of a list of stressful life events they have experienced during a given 
period.  The more subjective concepts, such as perceived stress and anxiety, 
questionnaires include items such as “how often have you felt nervous and stressed?” and 
provide a range of answer options (“never” to “always”).  Alternatively, a common 
model in psychoneuroimmunological research is to compare people experiencing a 
chronic stress, such as spousal caregiving, with matched controls who are not 
experiencing that particular stressor.  Although such a methodology has the disadvantage 
of between-subject variability, it allows the effect on immunity of a specific severe 




3.  Psychological stress and antibody response to vaccination 
 
The studies included in this review are summarised in Table 1.  A review of the literature 
was performed by interrogating PubMed (National Library of Medicine) and Web of 
Science (Institute for Scientific Information) databases, using the search terms “vaccin*”, 
“immuni*” and “inoculat*”.  These search terms were combined with the terms “stress”, 
“mood”, “psycho*”, “anxi*”, and “depress*”.  Only papers with antibody titre as an 
outcome measure were included.   In addition, the references in the articles that were 
generated by this search were checked. 
     
[Insert Table 1 about here] 
 
3.1  Secretory IgA responses 
 
In early studies, participants were immunised with non-pathogenic proteins to 
examine their antigen-specific antibody response.  Stone and colleagues [29, 30] required 
participants to swallow a capsule containing rabbit albumin each morning for 8-12 
weeks, and then measured the daily specific sIgA response in saliva, as well as daily 
mood [29] and events [30].  This methodology allowed within-subject comparisons 
between antibody levels on high-stress and low-stress days.  Antigen-specific sIgA 
antibody levels were lower on days with relatively high-negative mood and were elevated 
on days with relatively high-positive mood [29].  Subsequent research demonstrated a 
positive association between daily positive events and levels of antigen-specific sIgA 
and, conversely, a negative association between negative events and sIgA [30].  While 
variations in the salivary antibody levels to this antigen could be indicative of a general 
reduction in the ability of the immune system to respond [31], the clinical interpretation 
of changes in immune response to the oral ingestion of a non-pathogenic challenge 
remains unclear. 
3.2  Thymus-dependent vaccinations  
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Primary immune response has also been assessed using keyhole limpet 
hemocyanin (KLH), a protein antigen that is unlikely to have been encountered 
previously and which elicits a thymus-dependent antibody response [32].  At eight weeks 
post-vaccination, but not three weeks, the KLH-specific IgG response was significantly 
lower in those reporting fewer positive events prior to vaccination; an increase in the 
number of negative events also tended to be associated with impaired antibody response.  
Antibody status was not, however, related to the amount of stress experienced between 
vaccination and follow-up.  These data provide limited evidence that the antibody 
response to a single antigenic exposure may be susceptible to psychological influences.  
More recently, a small study investigating the effect of distress on antibody response to 
KLH failed to find any association between mood state and antibody status at three weeks 
[33].  However, this study did not include any of the typical measures of psychological 
stress, such as life event exposure and perceived stress levels.  
   
Response to medical vaccination provides a clinically relevant model of antigenic 
exposure.  The most commonly investigated vaccination is hepatitis B, probably due to 
the availability of large numbers of medical school students routinely being immunised.  
The complexity of the standard hepatitis B vaccination programme, consisting of three 
separate injections, administered at zero, one, and six months, and the low probability of 
prior naturalistic exposure, mean that both primary and secondary antibody responses can 
be assessed.  Two studies have investigated the relationship between stress and primary 
antibody response, measured one month after the initial vaccination.  In the first, those 
who seroconverted, defined as the presence of measurable antibody after the first 
vaccination, reported less mean perceived stress and anxiety over the entire course of the 
vaccination than those who seroconverted later [34].  While it is initially unclear why 
stress and anxiety levels assessed some months later may be related to seroconversion, it 
is likely that these questionnaires measure, to some extent, trait or dispositional 
tendencies to report high stress and anxiety.  It seems feasible, therefore, that people who 
generally tend to perceive their lives as stressful would have higher mean stress scores 
and it is these individuals who showed lower antibody levels.  In an emotional expression 
intervention study, there was no difference between the antibody levels of the treatment 
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group and control group one month after the initial vaccination [35].  However, since no 
measures were taken to assess the ongoing psychological impact of the intervention, it is 
difficult to interpret these findings.  Accordingly, the evidence that stress affects the 
primary response to hepatitis B vaccination is limited, a conclusion also reached in 
another recent review [36].   
 
Six correlational studies have investigated the relationship between stress and 
secondary response to hepatitis B vaccination.  Again, the results are mixed.  The largest 
study examined the relationship between self-reported life events and final antibody titre 
in two cohorts of students [37].  In the recently vaccinated cohort, there was no 
significant association between any stress measure and antibody titre.  However, in the 
cohort vaccinated earlier, those participants reporting high levels of life events stress over 
the past year were two and a half times more likely to have an inadequate antibody level 
than those with low levels of stress.  This association withstood adjustment for variations 
in unhealthy behaviours (smoking, alcohol consumption, exercise, sleep) and coping 
style.  The results suggest that the immunogenicity of the hepatitis B vaccination may 
initially override any influence of psychological factors.  Further, the larger number of 
individuals with inadequate antibody titres in the early vaccination cohort provides more 
power to detect effects.  Nevertheless, this study implies that psychological stress may 
have its principal effects on the rate of deterioration of protection.  
 
Jabaaij and colleagues [38] found a poorer antibody response to a low dose 
hepatitis B vaccination in those with a higher Stress Index at two months after 
vaccination.  There was also a tendency for antibody titre to be related to the Stress Index 
at 6 months.  As antibody response was not assessed at other time points, it is not 
possible to ascertain whether the effect of stress was predominantly on initial 
seroconversion or maintenance of antibody levels.  It is also difficult to attribute the 
relationship between the stress score and antibody response to any specific aspect of 
stress as the Stress Index was a composite measure calculated from a life events checklist 
and a questionnaire assessing psychological symptoms.  A similar protocol carried out by 
these researchers using a standard vaccine dosage yielded no significant associations 
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between antibody status [39].  It is worth pointing out, however, that in this latter study 
there was no two month assessment of stress, which had predicted antibody response 
previously, and the six month measure of stress used was not associated with antibody 
status in their earlier study either.  The inconsistencies in methodology make it difficult 
to attribute the failure to find stress effects in the later study to the immunogenicity of the 
full-dose hepatitis B vaccination programme.   
 
In the Glaser study discussed earlier [34], no relationship was found between the 
secondary antibody response and either stress or anxiety.  Similarly, Marsland and 
colleagues [40] found no associations between life event stress or perceived stress and 
antibody status five months after initial vaccination.  However, those with low antibody 
responses did report higher levels of trait negative affect.  Finally, one study has reported 
a positive relationship between stress and hepatitis B antibody status [41].  Final antibody 
status was positively related to perceived life event stress, depression, and anxiety during 
the first six months of the protocol.  The use of a life events scale in which students were 
able to rate experiences as positive or negative is a strong methodology, allowing for 
individual differences in the interpretation of an event.  In addition, the relatively large 
number of participants and the consistency of the associations across different 
psychosocial measures make it difficult to dismiss this anomalous result.  The authors 
suggested that their unexpected finding may be a function of the relatively low levels of 
stress of participants. This implies a curvilinear relationship between stress and antibody 
status, such that moderate levels of life-change stress are associated with higher levels of 
antibody response to vaccination, whereas low or high levels may be detrimental.   
 
The only study examining stress and hepatitis B antibody status that adopted an 
experimental, rather than correlational, design is the intervention study described earlier 
[35].  Participants in the emotional expression group exhibited higher antibody levels at 
both four and six month follow-up periods, compared to controls.   This contrasts with 
the primary antibody response results.  However, since the efficacy of the intervention 
was not assessed, it is difficult to definitively attribute the enhanced antibody levels in the 
experimental group to reduced psychological stress.   
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 Studies of the influenza vaccination hold particular clinical relevance considering 
the poor efficacy of the vaccine, particularly among the elderly [42].  An early study 
found no relationship between life change stress or mood state and antibody response to 
influenza vaccination [43].  More recently, a study by Kiecolt-Glaser and colleagues [44] 
used the caregiver-control model in which spousal caregivers were compared to age-
matched controls.  Caring for an elderly spouse is acknowledged as being arduous and 
prolonged [45] and, therefore, it is possible to use this model to assess the effects of a 
severe, chronic stressor on response to influenza vaccination.  Spousal care-givers and 
controls were administered the influenza vaccine, and their antibody responses assessed.  
Following vaccination, fewer care-givers achieved the four-fold increase in antibody 
level that can be used as a marker of vaccination success [46].  These findings were 
independent of variations in the measured health behaviours and medical conditions.  
Another study has also found that spousal care-givers displayed poorer antibody 
responses to influenza vaccination compared with controls [47].  However, caregivers are 
likely to differ from controls in a number of respects other than psychological stress, such 
as experiencing more physical strain.  Importantly, it has been shown that former spousal 
care-givers display the same impaired antibody response to influenza vaccination as 
current care-givers [48].  While much of the physical demand of care-giving would 
terminate with bereavement, it is reasonable to presume that psychological stress would 
continue.  This argues that the poorer responses to vaccination observed for the 
caregivers is a result of psychological stress rather than physical strain.  Finally, a recent 
study has investigated the association between perceived stress and response to influenza 
vaccine in a healthy, elderly population [49].  Higher levels of perceived stress were 
associated with lower anti-influenza IgG titre, supporting the previous research in elderly 
people.  However, the lack of a pre-immunisation antibody titre is a limitation of this 
study . 
 
The relationship between stress and antibody response to influenza vaccination 
has also been assessed in young adults [50-53].  In an early study, students reporting 
more distress, as measured by the Profile of Mood States questionnaire, had significantly 
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smaller antibody responses to the vaccine three weeks later [50].  Differences between 
those who did and did not achieve a four-fold increase in antibody were not reported.  In 
three recent studies [51-53], little evidence of suppression of antibody response at one 
month was found; indeed, two studies reported an unexpected positive association 
between stress and antibody response to at least one viral strain [51, 53].  However, in 
both studies with longer-term follow-ups, those who failed to maintain an antibody level 
four-times above baseline at this later time-point had significantly higher levels of 
psychological stress than those who maintained protective levels.  Thus, there is some 
evidence that psychological stress exerts a deleterious influence on antibody response to 
influenza vaccination in younger, healthy samples, although, in the main, this does not 
appear until some time after vaccination.  
 
As yet, only one study has investigated the effects of psychological factors on 
response to live-attenuated rubella vaccination.  Among the girls who were seronegative 
for antibodies against rubella virus, and, therefore, for whom vaccination elicited a 
primary antibody response, those high in internalising (characterised by withdrawal and 
anxiety), high in neuroticism (emotional instability), and low in self-esteem had lower 
antibody titres.  In contrast, in the girls who exhibited antibodies against rubella prior to 
vaccination, for whom this was a secondary response, no relationships between 
psychological status and immunity were found [54].   
 
3.3  Thymus-independent vaccinations 
 
The only thymus-independent vaccination to receive attention so far is that 
against pneumococcus, and two very different populations have been studied.  The earlier 
study was carried out in five-year-old children, who were administered the pneumococcal 
vaccination one week before the start of kindergarten [55].  Ratings of problem behaviour 
were not associated with antibody response to the vaccine.  The other study to have 
investigated stress and pneumococcal vaccination compared spousal care-givers, former 
care-givers, and age-matched controls [56]. Although there were no group differences 
either two weeks or one month after the vaccination, current care-givers had poorer 
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specific antibody titres three and six months after receiving the pneumococcal 
vaccination compared to the other two groups. This suggests that care-giving impacts on 
the rate of deterioration of protection, rather than on the initial response to vaccination.   
 
3.4   Conjugate vaccinations 
 
A third type of vaccination is the conjugate vaccine.  A successful strategy in 
vaccination programmes against thymus-independent, polysaccharide antigens, has been 
to conjugate the polysaccharide to a protein molecule in order to invoke a thymus-
dependent antibody response.  The mechanisms of antibody production are, therefore, 
thymus-dependent, yet the antibody that is produced is against a polysaccharide thymus 
independent type 2-antigen.  The role of psychosocial factors in the antibody response to 
a conjugate vaccine has only been assessed in one study [57].  Participants with high 
levels of perceived stress and psychological distress were more likely to have low 
antibody titres.  Life events exposure was not predictive of antibody titre, and none of the 
psychological variables were significantly associated with serum bactericidal assay titre, 
which measures the ability of antibodies to kill meningitis bacteria.  These findings 
suggest that the feeling that one’s life is stressful and the experience of high levels of 
distress were more detrimental than actual exposure to stressful life events.  Importantly, 
there was also an interaction between perceived stress and life event exposure.  Those 
people who reported being high in perceived stress yet experiencing relatively few 
stressful life events were significantly more likely to have low antibody titres and serum 
bactericidal assay titres than any other group, including those high in both perceived 
stress and life event exposure.  The negative influence of these context-inappropriate 
perceptions of stress suggest that personality factors may also be implicated in 
determining the adequacy of the antibody response.  This resonates with the results 
reported for thymus-dependent vaccinations, in which higher negative affect [40], 
neuroticism [54], and psychological symptoms [38] are associated with poorer antibody 
titres, and suggests that conjugate vaccines may be similarly susceptible to psychological 
influence.    
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4.  Potential mechanisms of interaction between stress and immunity 
 
4.1  Indirect mechanisms 
 
An association between stress and antibody response to vaccination could arise 
from direct and/or indirect mechanisms.  The most likely indirect mechanisms are 
changes in health behaviours, often associated with periods of stress, and their subsequent 
physiological impact on antibody formation.  High levels of stress have commonly been 
associated with increases in unhealthy behaviours such as smoking, excessive alcohol 
consumption, a poorer diet, and decreased time spent exercising [58-60].  In addition, 
high levels of alcohol consumption have been linked to reduced vaccine efficacy [61] and 
alcoholics have been shown to have poorer responses to some serotypes of the 
pneumococcal vaccine than non-alcoholic controls [62].  Similarly, cigarette smoking has 
been linked to reduced response to influenza [63, 64], and hepatitis B vaccinations [65-
67].  It has also been suggested that nutritional status may influence vaccine efficacy; 
supplementation with zinc, selenium [68], and vitamin E [69] improved the response to 
influenza vaccination in institutionalised elderly participants.  In addition, in 
malnourished patients, appropriate supplementation can also improve response to the 
influenza vaccination [70].  In spite of these findings, some studies have failed to 
adequately control for health behaviours, leaving open the possibility that at least some of 
the observed association between stress and antibody status may be attributable to 
variations in unhealthy behaviours.   
 
4.2  Direct mechanisms 
 
More direct mechanisms of interaction between stress and immune function have 
also been postulated [10].  Stress is associated with alterations in sympathetic nervous 
system and hypothalamic-pituitary-adrenal axis activation.  Functional relationships 
between these neuroendocrine pathways and the immune system have been 
acknowledged for some time (for a review see [10]).  Therefore, it is feasible that 
changes in basal activity in these systems, or their repeated activation in response to 
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stress, could impact upon antibody development and maintenance.  Finally, individual 
differences in the extent to which these systems respond to standardised stressors have 
been shown to be predictive of reactivity to real-life stressors [71]; those with high 
physiological reactivity to psychological stress may, through repeated, large magnitude 
responses to stressful situations, be most at risk of stress-related reductions in immune 
function.   
 
4.2.1  Hypothalamic-pituitary-adrenal axis  
 
Spousal caregivers, shown to have lower antibody responses to influenza vaccine, 
also had higher mean salivary cortisol values, than controls.  There was also a negative 
correlation between mean resting cortisol concentrations and antibody response to one 
viral strain [47].  In contrast, basal salivary cortisol and antibody response to hepatitis B 
vaccination have been found to be correlated positively [72] and a null result has recently 
been observed for influenza vaccination [53].  
 
The evidence regarding cortisol reactions to stress is more consistent.  Cortisol 
reactivity is calculated as the post-stress cortisol level minus baseline.  Children showing 
the greatest cortisol reaction to the stress of starting kindergarten had the poorest 
response to pneumococcal vaccination [55].  Similarly, relative to individuals with high 
hepatitis B antibody titres, those with low titres were characterised by more positive 
cortisol reactions to an acute laboratory time-pressured, socially evaluated mental 
arithmetic task [72].  In  addition, students with the most marked cortisol reaction to the 
naturalistic stress of blood sampling and vaccination showed a poorer antibody response 
at five months to one strain of the influenza vaccine [53].   
 
4.2.2  Sympathetic nervous system activation 
 
The sympathetic nervous system provides another possible link between stress 
and immune function, either in the form of catecholamine secretion or via the direct 
innervation of the lymphoid organs [73].  The study discussed above [72] also addressed 
 14 
the association between cardiovascular reactivity to a mental stress task, as a marker of 
sympathetic nervous system (SNS) reactivity, and antibody response to hepatitis B 
vaccination.  Compared to those with high antibody titres, participants with low antibody 
titres had heightened SNS reactions to stress.  This suggests that reactivity may be 
detrimental to either initial antibody response or continued antibody protection.  In 
addition, one small study reported that individuals with relatively large sympathetically-
mediated cardiovascular reactions to a standard laboratory stress task showed a more 
rapid decline over time in the T-lymphocyte response to influenza vaccination [53].   
 
Marsland [40] provides further evidence of an association between physiological 
reactivity and antibody response to vaccination.  Participants were asked to perform an 
evaluated speech task, during which cardiovascular and immune measures were assessed.  
It was found that those who exhibited greater deteriorations in lymphocyte proliferation 
to mitogen following an acute stressor, compared to baseline, had also responded less 
well to a hepatitis B vaccination programme completed two months earlier.  There were 
significant associations between decreases in proliferative response to mitogen and stress-
induced heart rate acceleration, an indirect, albeit weak, measure of sympathetic 
activation.  It is possible, therefore, that variations in SNS activation could account for 
the differences in vaccine-specific antibody levels, via a decrease in the functional 
capacity of the lymphocytes [40].  
     
5.  Strategies/areas for future research 
 
Overall, there is now sufficient indicative evidence to justify further, more 
carefully designed, studies.  In designing such studies, investigators should consider 
whether their primary concerns lie with clinical or theoretical issues; while the 
vaccination model has important implications for both, future studies would almost 




5.1  Clinical studies 
 
If stress is associated with response to vaccination, a key question for clinicians is 
how can this result be exploited by health care professionals for the benefit of patients?  
Clinical research should first focus on populations that are likely to be most susceptible to 
the influence of stress.  Two-thirds of the studies reviewed here involved young, healthy 
students, who are unlikely to have poorly functioning immune systems or to be 
experiencing high levels of chronic stress.  It is a tribute to the magnitude of stress effects 
on antibody response that, on the whole, effects were still found in this relatively robust 
population, but it would now seem sensible to turn attention to more vulnerable 
populations.   
 
Future studies of stress and response to vaccination should, where possible, include 
assessment of vaccine efficacy in terms of disease incidence and severity.  As there is 
evidence that antibody responses to influenza vaccination in elderly populations are 
frequently insufficient to provide protection against disease [74, 75], further deterioration in 
protection due to chronic stress may be particularly detrimental to the health of the elderly.  
However, in the absence of direct measures of infection, it is difficult to determine the true 
impact of stress on the health of susceptible populations.  If clinical outcomes, as well as a 
simple antibody count, are associated with stress exposure, more routine antibody testing of 
elderly recipients of the influenza vaccine is indicated, particularly in those with other risk 
factors, such as respiratory conditions.   
  
Clinical research should also focus on what might be done to counteract the 
potentially deleterious impact of stress on antibody response.  Only one intervention 
study has been published so far [35].  While the finding that people undergoing a trauma 
disclosure procedure showed better responses to hepatitis B vaccination than control 
participants is encouraging, it is necessary to test the efficacy of more mainstream stress 
management strategies, as well as assessing formally whether such strategies have 
ameliorated perceptions of stress.  It is also worth exploring manipulations of the timing 
of vaccination.  Randomised controlled trials of a variety of populations with predictable 
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periods of stress, such as students, teachers, medical, or military personnel, should be 
undertaken, with participants being vaccinated during either high or low stress periods.  
Such a simple intervention could prove informative for clinical practice.   
 
5.2  Theoretical studies 
 
A more theoretical goal should be to establish which aspects of the antibody 
response are affected by psychological stress.  By differentiating between vaccines 
inducing thymus-dependent and thymus-independent antibody responses as outlined in 
this review, the relative susceptibility of different types of antibody response may be 
ascertained.  In addition, enumerative and in vitro functional immune measures could be 
used in conjunction with the antibody response model in order to further elucidate exactly 
which immune parameters or reactions are sensitive to stress. 
 
The stage at which the antibody response to vaccination is most affected by stress 
exposure is another important theoretical consideration.  There is increasing evidence 
now that the detrimental effects of stress may not be apparent until several months after 
vaccination [37, 52, 53, 56], suggesting that the maintenance of antibody production 
might be more vulnerable to stress than initial antibody production.  This may also 
explain some of the null findings [33, 39] in which only short follow-ups have taken 
place.  Indeed, there is growing evidence that acute stress may potentiate the initial 
antibody response [41, 51, 53, 76].  This hypothesis is also supported by recent stress and 
vaccination research in animal models [77].  Future studies should involve serial blood 
testing during both antibody formation and long-term follow-ups in order to investigate 
these issues further.   
 
Current research suggests that secondary responses may be more susceptible to 
stress than primary responses [36].  However, given the limited evidence concerning 
primary responses, this conclusion should be considered tentative.  Immunisation with a 
novel antigen, such as KLH, avoids experimental contamination by naturalistic exposures 
and would allow a primary antibody response to be investigated.  Booster immunisation 
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would then allow investigation of the impact of stress during both the primary response 
and the secondary response on the secondary antibody response itself.  This methodology 
could be combined with the serial blood testing suggested above, in order to assess the 
dynamics of the antibody response with respect to immunoglobulin class (primarily IgM 
versus IgG and IgA) and affinity for antigen.  This would provide further important 
insights into which aspects of the immune process are modulated by stress.   
 
Studies might also pay attention to the methods used to assess stress exposure.  If 
this is to be achieved by questionnaire, separate and validated measures of life events 
exposure, perceived stress, and psychological distress, are to be preferred to the 
composite measures of stress that have sometimes been used previously [38].  This 
approach would allow a better understanding of the extent to which immune function is 
affect be exposure to stressful life events, perceptions of stress, or an interaction between 
the two.  In addition, it would be sensible for future studies to measure positive, as well 
as negative, life events; a stronger relationship with antibody response to KLH appeared 
for the absence of positive events than for the occurrence of negative events [32].  
Finally, it is also important to differentiate more clearly between state and trait measures 
of psychological status.  Several studies have indicated that trait-like measures of stress 
and anxiety may be better predictors of antibody status than more transient, state-like 
measures [34, 54].   
 
Some studies have adopted a between-group comparison of high and low stress 
participants [44, 47, 56], which has the advantage of examining more chronic, enduring 
stressors than those commonly assessed in questionnaire-based studies.  However, as 
with all between-group assessments, it is critical to control for as many extraneous 
variables as possible.  When carefully designed though, this quasi-experimental, 
between-group model provides an important opportunity to study the effects of severe, 
chronic stress on antibody response to vaccination.  Future research could exploit this 
method more widely, by examining a greater range of stress exposures in a wider variety 
of populations.  However, it is also important to retain a subjective component to the 
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stress assessment; individual differences in the perception of the psychological demands 
placed on an individual by a particular situation could be key.  
 
Finally, we would also argue for more focus on potential mechanisms.  Many 
studies did not control for health behaviours [41, 47, 50, 54, 76]; the vast majority of the 
studies that do [34, 37-39, 44, 53, 56, 57] use less-than-optimal brief retrospective 
questionnaires.  In order to fully address the potential role of health behaviours, more 
investigators could include detailed day-by-day assessments as were performed in the 
exemplary study of Pressman and colleagues [52] or objective measures of health 
behaviours, such as cotinine to assess cigarette smoking.  Without such steps, the role of 
health behaviour as a mediator between stress and health may continue to be 
underestimated.  In terms of more direct mechanisms, larger studies of basal cortisol, 
with more detailed diurnal profiles, or, perhaps, 24-hour urinary cortisol, are necessary to 
reconcile the contradictory findings reported thus far [47, 72].  Additionally, further 
investigations should test the stress reactivity hypothesis proposed by Cacioppo and 
colleagues [78].  Finally, greater range of potential mechanisms need to be examined.  
The potential involvement of opioids, cytokines, and neuropeptides have received 
relatively little attention in human psychoneuroimmunological research (for a review, see 
[10]), and none at all in the context of stress-induced modulation of antibody response.   
    
6.  Conclusion 
 
There is evidence of a negative association between stress and antibody response 
to vaccination.  This is most apparent in secondary responses to thymus-dependent 
vaccinations, particularly the influenza vaccine [44, 47, 52, 53], and the associations 
seem most convincing with stressors of a chronic, enduring nature [34, 44, 47].  There is 
also increasing evidence that these effects are most apparent some time after vaccination.  
Thymus-independent and conjugate vaccinations have received insufficient study to 
permit definitive conclusions.  The existing preliminary evidence implicates the HPA 
axis and SNS as mediators of the association between stress and antibody response.  
Future research needs to untangle the theoretical ramifications of these data, as well as 
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